In conclusion, this study shows that despite treatment during pregnancy, women with GDM diagnosed using the WHO 2013 criteria remain at increased risk of AGT and adverse metabolic profile 10 years after the index pregnancy. This evidence concerns the gene AGT and gestational diabetes.